Ginkgo Bioworks Adopts Inscripta®’s Onyx® Digital Genome Engineering Platform to Continue Accelerating its Genome Editing Throughput
January 10, 2022
Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell…
Read More